ST. LOUIS, Jan. 31, 2011 /PRNewswire/ -- Sigma-Aldrich®
Corporation (Nasdaq: SIAL) announced today that it has acquired the
assets of Resource Technology Corporation (RTC) of Laramie, Wyoming, an industry leader in
analytical standards and certified reference materials. The
acquisition of RTC's business complements the recently completed
acquisition of Cerilliant Corporation, and further expands and
strengthens Sigma-Aldrich's analytical chemistry offerings, a key
goal in assisting the Company in delivering on its strategic sales
growth plans. Terms of the purchase were not disclosed.
The RTC product offerings also complement the Company's
well-regarded Supelco and Fluka brand analytical reagents,
standards and separation consumables with the addition of its core
expertise in design, development, characterization and packaging of
analytical standards, matrix standards, certified reference
materials and proficiency testing. With this acquisition,
Sigma-Aldrich now serves a wide range of applications, including
the fast-growing environmental and pharmaceutical sectors.
"The strong and innovative products offered by RTC bring new
opportunities for expanding our business," commented Russel Gant, Vice President of the Analytical
Research business for Sigma-Aldrich. "Their experienced team,
capabilities and customer contacts combine nicely with our breadth
of product, high-quality portfolio, extensive scientific knowledge
and global footprint. The RTC acquisition will allow Sigma-Aldrich
to provide customers with an even broader range of specialized,
analytical standards and services."
This is the second acquisition made by Sigma-Aldrich in recent
weeks. In December 2010, the Company
acquired Cerilliant Corporation, an industry leader in supplying
high quality reference standards and materials that support the
clinical diagnostics, environmental, nutraceutical, pharmaceutical,
forensic and clinical toxicology markets.
Cautionary statement: The foregoing release contains
forward-looking statements that can be identified by terminology
such as "strengthens," "expands," "expects," or similar
expressions, or by expressed or implied discussions regarding
potential future revenues from products derived therefrom. You
should not place undue reliance on these statements. Such
forward-looking statements reflect the current views of management
regarding future events, and involve known and unknown risks,
uncertainties and other factors that may cause actual results to be
materially different from any future results, performance or
achievements expressed or implied by such statements. There can be
no guarantee that the acquisition of the business of RTC will
achieve any particular levels of revenue in the future. In
particular, management's expectations regarding the acquisition of
the RTC business could be affected by, among other things,
unexpected regulatory actions or delays or government regulation
generally; the Company's ability to obtain or maintain patent or
other proprietary intellectual property protection; competition in
general; government, industry and general public pricing pressures;
the impact that the foregoing factors could have on the values
attributed to the Company's assets and liabilities as recorded in
its consolidated balance sheet, and other risks and factors
referred to in Sigma-Aldrich's current Form 10-K on file with the
US Securities and Exchange Commission. Should one or more of these
risks or uncertainties materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated, believed, estimated or expected.
Sigma-Aldrich is providing the
information in this press release as of this date and does not
undertake any obligation to update any forward-looking statements
contained in this press release as a result of new information,
future events or otherwise.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High
Technology company committed to Enabling Science to Improve the
Quality of Life. Its chemical and biochemical products and kits are
used in scientific research, including genomic and proteomic
research, biotechnology, pharmaceutical development and as key
components in pharmaceutical, diagnostic and other high technology
manufacturing. The Company has customers in life science companies,
university and government institutions, hospitals, and in industry.
More than one million scientists and technologists use its
products. Sigma-Aldrich operates
in 40 countries and has 7,900 employees providing excellent service
worldwide. For more information about Sigma-Aldrich, please visit
its award-winning Web site at http://www.sigma-aldrich.com.
Sigma-Aldrich is a trademark of
Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.
SOURCE Sigma-Aldrich Corporation